JP2025516315A5 - - Google Patents
Info
- Publication number
- JP2025516315A5 JP2025516315A5 JP2024564932A JP2024564932A JP2025516315A5 JP 2025516315 A5 JP2025516315 A5 JP 2025516315A5 JP 2024564932 A JP2024564932 A JP 2024564932A JP 2024564932 A JP2024564932 A JP 2024564932A JP 2025516315 A5 JP2025516315 A5 JP 2025516315A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- compound according
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338264P | 2022-05-04 | 2022-05-04 | |
| US63/338,264 | 2022-05-04 | ||
| US202263411405P | 2022-09-29 | 2022-09-29 | |
| US63/411,405 | 2022-09-29 | ||
| PCT/US2023/020978 WO2023215465A1 (en) | 2022-05-04 | 2023-05-04 | Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516315A JP2025516315A (ja) | 2025-05-27 |
| JP2025516315A5 true JP2025516315A5 (cg-RX-API-DMAC10.html) | 2026-05-13 |
Family
ID=88647025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564932A Pending JP2025516315A (ja) | 2022-05-04 | 2023-05-04 | 置換イミダゾピリジンおよびイミダゾピリミジン、ならびに網膜変性を処置、改善、および／または予防するためのその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250288588A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4519268A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025516315A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119487033A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023265523A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3251997A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023215465A1 (cg-RX-API-DMAC10.html) |
-
2023
- 2023-05-04 EP EP23800027.7A patent/EP4519268A1/en active Pending
- 2023-05-04 AU AU2023265523A patent/AU2023265523A1/en active Pending
- 2023-05-04 JP JP2024564932A patent/JP2025516315A/ja active Pending
- 2023-05-04 CA CA3251997A patent/CA3251997A1/en active Pending
- 2023-05-04 CN CN202380050874.5A patent/CN119487033A/zh active Pending
- 2023-05-04 WO PCT/US2023/020978 patent/WO2023215465A1/en not_active Ceased
- 2023-05-04 US US18/862,727 patent/US20250288588A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104520268B (zh) | Ssao的取代的3‑卤代烯丙基胺抑制剂及其用途 | |
| JP2020530470A5 (cg-RX-API-DMAC10.html) | ||
| RU2632107C2 (ru) | Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник | |
| GB2540638A (en) | Compositions, Formulations and methods for treating ocular diseases | |
| JP2014502979A5 (cg-RX-API-DMAC10.html) | ||
| JP2013544786A5 (cg-RX-API-DMAC10.html) | ||
| KR20100131976A (ko) | 고 안압증의 치료를 위한 디플루오로바이페닐아미드 유도체 | |
| JP2017531022A (ja) | シクロスポリン及びトレハロースを含む眼科用組成物 | |
| JP2025032189A (ja) | ５′－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 | |
| JP2023506838A5 (cg-RX-API-DMAC10.html) | ||
| JP2018100222A (ja) | 角膜損傷の治療剤、改善剤または予防剤 | |
| ES3002189T3 (en) | Para-hydroquinone derivatives as vegf, tnf and/or il inhibitors for the treatment of neuroinflammatory diseases | |
| CN111315369A (zh) | 用于治疗眼部病症和皮肤疾病的化合物、组合物和方法 | |
| JP2020511437A5 (cg-RX-API-DMAC10.html) | ||
| JPWO2020009248A5 (cg-RX-API-DMAC10.html) | ||
| TW201323425A (zh) | 抗菌性咔啉化合物 | |
| JP5955774B2 (ja) | プロスタグランジンアゴニストのプロドラッグの安定した水性組成物およびその使用方法 | |
| JP2021138710A5 (cg-RX-API-DMAC10.html) | ||
| JP2021113185A5 (cg-RX-API-DMAC10.html) | ||
| JP2012006918A (ja) | イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤 | |
| KR20120081585A (ko) | 안질환을 치료하기 위한 이소티오졸 | |
| CN101784285B (zh) | 用于与低氧或局部缺血有关的眼科疾病的组合物 | |
| JP2025532951A (ja) | 移植関連不整脈を処置するための組成物および方法 | |
| JP2021147392A5 (cg-RX-API-DMAC10.html) | ||
| RU2351586C2 (ru) | Васкулостатические агенты и способы их применения |